Delivery Order SPE2DB25D2207-SPE2DB25FQQKF

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $9,319.47 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the prescription drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen...
This is a $7,950.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pen. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a ceiling value of $20,165.02 and a period of performance through October 26, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 12.5 mg/0.5 mL pens. The contract, valued at $1,578.00, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed price pricing type. The contract has an ultimate completion date of November 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen is the prime contractor, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The award, valued at $10,221.48, is a delivery order under an Indefinite Delivery Contract (IDC) with a total potential value of up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens. The contract has a firm fixed price of $5,189.64 and a completion date of August 1, 2024. This is a delivery order contract, which is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between AmerisourceBergen and the DLA...
This federal contract award is to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, to supply the Defense Logistics Agency (DLA) Troop Support Medical with the drug Mounjaro (Tirzepatide) 10 mg/0.5 mL pens. The delivery order is valued at $9,226.10 and has a completion date of September 18, 2024. This contract is not set aside for a specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $18,194.72, is for the supply of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,030.08, is for the supply of the drug Mounjaro (tirzepatide) 10 mg/0.5 ml pens. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,321.04, is for the procurement of the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a firm fixed-price pricing type and an ultimate completion date of January 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at...
  • SPE2DB25D2207
    Indefinite Delivery Contract
  • SPE2DB25D2207-SPE2DB25FQQKF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $9,954.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:05 PM